152 related articles for article (PubMed ID: 17868485)
1. Elevated HCG outside of pregnancy--diagnostic considerations and laboratory evaluation.
Olsen TG; Barnes AA; King JA
Obstet Gynecol Surv; 2007 Oct; 62(10):669-74; quiz 691. PubMed ID: 17868485
[TBL] [Abstract][Full Text] [Related]
2. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
Cole LA; Butler S
J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
[TBL] [Abstract][Full Text] [Related]
3. [The follow-up of trophoblastic disease by using an hCG-CTP enzyme immunoassay].
Matsuura Y; Kashimura M; Shinohara M; Baba S; Kondo M; Kashimura Y
Gan No Rinsho; 1990 Dec; 36(15):2559-62. PubMed ID: 2176247
[TBL] [Abstract][Full Text] [Related]
4. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases.
Cole LA; Shahabi S; Butler SA; Mitchell H; Newlands ES; Behrman HR; Verrill HL
Clin Chem; 2001 Feb; 47(2):308-15. PubMed ID: 11159780
[TBL] [Abstract][Full Text] [Related]
5. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum beta-human chorionic gonadotropin in nonpregnant conditions.
Demirtas E; Krishnamurthy S; Tulandi T
Obstet Gynecol Surv; 2007 Oct; 62(10):675-9; quiz 691. PubMed ID: 17868483
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of human chorionic gonadotropin and alpha-subunit measurements.
Hussa RO
Obstet Gynecol; 1982 Jul; 60(1):1-12. PubMed ID: 6283446
[TBL] [Abstract][Full Text] [Related]
8. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
[TBL] [Abstract][Full Text] [Related]
9. [Molecular heterogeneity of hCG in urine of the patients with trophoblastic diseases].
Kitajima T; Mochizuki M; Nishimura R
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):297-303. PubMed ID: 1710641
[TBL] [Abstract][Full Text] [Related]
10. Clinical use of HCG and hCG beta determinations.
Mann K; Saller B; Hoermann R
Scand J Clin Lab Invest Suppl; 1993; 216():97-104. PubMed ID: 7690985
[TBL] [Abstract][Full Text] [Related]
11. [HCG and SP-1 as markers in trophoblast tumors. The HCG/SP-1 ratio].
Than GN; Tatra G; Csaba IF; Szabo DG; Bohn H
Gynakol Rundsch; 1988; 28(3):157-65. PubMed ID: 2844633
[No Abstract] [Full Text] [Related]
12. Human chorionic gonadotropin assays and their uses.
Tyrey L
Obstet Gynecol Clin North Am; 1988 Sep; 15(3):457-75. PubMed ID: 2852329
[TBL] [Abstract][Full Text] [Related]
13. Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotropin.
Khanlian SA; Cole LA
J Reprod Med; 2006 Oct; 51(10):812-8. PubMed ID: 17086809
[TBL] [Abstract][Full Text] [Related]
14. Non trophoblastic source of human chorionic gonadotropin - problem in diagnostic accuracy.
Dabrowski F; Grzechocinska B; Cyganek A; Wielgos M
Neuro Endocrinol Lett; 2015; 36(4):316-9. PubMed ID: 26454486
[TBL] [Abstract][Full Text] [Related]
15. Human chorionic gonadotropin in cancer.
Stenman UH; Alfthan H; Hotakainen K
Clin Biochem; 2004 Jul; 37(7):549-61. PubMed ID: 15234236
[TBL] [Abstract][Full Text] [Related]
16. Gestation trophoblastic diseases: management of cases with persistent low human chorionic gonadotropin results.
Cole LA; Kohorn E; Smith HO
Obstet Gynecol Clin North Am; 2005 Dec; 32(4):615-26. PubMed ID: 16310675
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
Grinevich IuA; Tatarinov IuS; Iugrinova LG; Olefirenko GA; Dotsenko IuS
Vopr Onkol; 1981; 27(12):19-23. PubMed ID: 6275607
[TBL] [Abstract][Full Text] [Related]
18. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
Cole LA; Sutton JM
J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826
[TBL] [Abstract][Full Text] [Related]
19. Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels.
Cole LA; Kohorn EI; Kim GS
J Reprod Med; 1994 Mar; 39(3):193-200. PubMed ID: 8035374
[TBL] [Abstract][Full Text] [Related]
20. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
Than GN; Csaba IF; Bohn H; Szabó DG; Szalmásy M; Menczer G
Oncodev Biol Med; 1982; 3(4):315-23. PubMed ID: 6291007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]